Recent research in The Lancet points to the evidence that RMNCH+A outcomes, like the under-five mortality rate, can be substantially improved by 2035 with the right investment plan. In our report, we first present those estimates for India and point to potential participants who could bridge the gap. We then demonstrate that investing in this strategic approach is reasonable.To prepare this report, we studied the outcomes associated with the RMNCH+A approach, observed the progress made to date and noted the distance from the target. We also studied the private, public and philanthropic sectors' participation to determine where there are gaps in their engagement. Finally, our report articulates where the RMNCH+A sector is in its evolution.